Jacqueline L. Kloth
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors.
Journal: The pharmacogenomics journal
Published: June 04, 2018
Disentangling the genetics of lean mass.
Journal: The American journal of clinical nutrition
Published: March 22, 2018
Erratum: Large meta-analysis of genome-wide association studies identifies five loci for lean body mass.
Journal: Nature communications
Published: November 09, 2017
Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 22, 2017
Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure.
Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure.
Journal: Clinical pharmacokinetics
Published: July 28, 2016
Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 12, 2015
Large meta-analysis of genome-wide association studies identifies five loci for lean body mass.
Journal: Nature communications
Published: August 17, 2015
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
Journal: Breast cancer research and treatment
Published: February 24, 2015
Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence.
Journal: Clinical pharmacokinetics
Published: February 04, 2015
Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662.
Journal: British journal of clinical pharmacology
Published: September 02, 2014
Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study.
Journal: Clinical pharmacokinetics
Published: November 16, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026